Angiogenic signaling pathways and anti-angiogenic therapy for cancer

ZL Liu, HH Chen, LL Zheng, LP Sun… - Signal transduction and …, 2023 - nature.com
Angiogenesis, the formation of new blood vessels, is a complex and dynamic process
regulated by various pro-and anti-angiogenic molecules, which plays a crucial role in tumor …

Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy

RL Barrett, E Puré - Elife, 2020 - elifesciences.org
Fibroblasts play an essential role in organogenesis and the integrity of tissue architecture
and function. Growth in most solid tumors is dependent upon remodeling 'stroma', composed …

Oncologic photodynamic therapy: basic principles, current clinical status and future directions

D Van Straten, V Mashayekhi, HS De Bruijn, S Oliveira… - Cancers, 2017 - mdpi.com
Photodynamic therapy (PDT) is a clinically approved cancer therapy, based on a
photochemical reaction between a light activatable molecule or photosensitizer, light, and …

Melissa officinalis L.–A review of its traditional uses, phytochemistry and pharmacology

A Shakeri, A Sahebkar, B Javadi - Journal of ethnopharmacology, 2016 - Elsevier
Ethnopharmacological relevance Melissa officinalis L. is a medicinal plant that has long
been used in different ethno-medical systems especially in the European Traditional …

The contribution of angiogenesis to the process of metastasis

DR Bielenberg, BR Zetter - The Cancer Journal, 2015 - journals.lww.com
The role of angiogenesis in tumor growth has been studied continuously for over 45 years. It
is now appreciated that angiogenesis is also essential for the dissemination and …

Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor‐2 inhibitor

C Xie, X Wan, H Quan, M Zheng, L Fu, Y Li… - Cancer …, 2018 - Wiley Online Library
Abrogating tumor angiogenesis by inhibiting vascular endothelial growth factor receptor‐2
(VEGFR 2) has been established as a therapeutic strategy for treating cancer. However …

[HTML][HTML] Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases

A Fallah, A Sadeghinia, H Kahroba, A Samadi… - Biomedicine & …, 2019 - Elsevier
Angiogenesis is a critical step in the progression of almost all human malignancies and
some other life-threatening diseases. Anti-angiogenic therapy is a novel and effective …

Bevacizumab plus ipilimumab in patients with metastatic melanoma

FS Hodi, D Lawrence, C Lezcano, X Wu, J Zhou… - Cancer immunology …, 2014 - AACR
Ipilimumab improves survival in advanced melanoma and can induce immune-mediated
tumor vasculopathy. Besides promoting angiogenesis, vascular endothelial growth factor …

Platelet-membrane-coated nanoparticles enable vascular disrupting agent combining anti-angiogenic drug for improved tumor vessel impairment

B Li, T Chu, J Wei, Y Zhang, F Qi, Z Lu, C Gao… - Nano Letters, 2021 - ACS Publications
Compared with traditional chemotherapeutics, vascular disruption agents (VDAs) have the
advantages of rapidly blocking the supply of nutrients and starving tumors to death. Although …

Pediatric osteosarcoma: an updated review

SJ Taran, R Taran, NB Malipatil - Indian Journal of Medical and …, 2017 - thieme-connect.com
Osteosarcoma (OS), the most common type of primary malignant bone tumor, is defined by
the presence of malignant mesenchymal cells producing osteoid or immature bone. The …